Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia

Kenji MotohashiDepartment of Hematology, Yokohama City University Medical Center, Minami-ku, Yokohama, Japan; Correspondence[email protected]

Shin FujisawaDepartment of Hematology, Yokohama City University Medical Center, Minami-ku, Yokohama, Japan;

Noriko DokiDivision of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan;

Takeshi KobayashiDivision of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan;

Takehiko MoriDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;

Kensuke UsukiDepartment of Hematology, NTT Medical Center Tokyo, Tokyo, Japan;

Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;

Shinichiro FujiwaraDivision of Hematology, Jichi Medical University, Shimotsuke, Japan;

Shinichi KakoDivision of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan;

Yasuyuki AoyamaDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan;

Masahiro OnodaDepartment of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan;

Shingo YanoDivision of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan;

Moritaka GotohDepartment of Hematology, Tokyo Medical University Hospital, Tokyo, Japan;

Heiwa KanamoriDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;

Satoshi TakahashiDepartment of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan

Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;

References